文献速递糖尿病骨质疏松与钙磷/甲状旁腺

年轻2型糖尿病患者的骨组织形态计量学受血糖控制与慢性并发症影响

Bone Histomorphometry in Young Patients With Type 2 Diabetes is Affected by Disease Control and Chronic Complications.
PubMed 文献 · J Clin Endocrinol Metab · 2020-01-01

结果显示骨体积分数在血糖控制良好组与不佳组均升高,而血糖控制不佳组及有慢性并发症组的骨样组织厚度小于对照组,HbA1c与骨样组织厚度、骨样表面呈负相关。

要点

  • 绝经前2型糖尿病女性中,骨体积分数在血糖控制良好与不佳组均高于对照。
  • 血糖控制不佳及合并慢性并发症者骨样组织厚度减小,提示骨形成受损。
  • HbA1c与骨样组织厚度、骨样表面负相关,支持血糖控制与骨质量相关。

核心结论

  • 绝经前2型糖尿病患者的骨组织形态计量学受疾病控制状态和慢性并发症影响。

研究设计与样本

  • 横断面研究,在三级医疗中心开展。
  • 进一步按有无慢性并发症分为有并发症组(n=9)与无并发症组(n=17)。
  • 对照组为按年龄、性别和种族匹配的15例。
  • 测量骨组织形态计量学参数及血清戊糖苷和IGF-1。

主要发现

  • 骨体积分数(BV/TV)在控制良好组(P < .001)和控制不佳组(P = .05)均升高。
  • 骨样组织厚度(O.Th)在控制不佳组小于对照组(P = .03)。
  • 有慢性并发症组骨样组织厚度小于对照组(P = .01),BV/TV与对照组相近(P = .11)。
  • HbA1c与骨样组织厚度(P = .02)和骨样表面(OS/BS,P = .01)呈负相关。
  • 骨组织形态计量学参数与戊糖苷和IGF-1无相关性。

关键数值与推荐

  • 血糖控制良好定义为HbA1c < 7%,控制不佳定义为HbA1c > 7%。
  • 骨体积分数在控制良好组P < .001、控制不佳组P = .05。
  • 骨样组织厚度在控制不佳组P = .03、有慢性并发症组P = .01。
  • HbA1c与骨样组织厚度P = .02、与骨样表面P = .01呈负相关。

临床怎么用

  • 对绝经前2型糖尿病女性,评估骨健康时应关注血糖控制水平与慢性并发症状态。
  • HbA1c较高或合并慢性并发症者可能存在骨样组织厚度减小,提示骨形成受损。
  • 骨组织形态计量学参数与戊糖苷、IGF-1无相关,暂不能以此作为替代指标。

局限性

  • 横断面设计,无法推断因果关系。
  • 仅纳入绝经前女性,结果外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Type 2 diabetes mellitus (T2DM) is associated with an increased risk of fractures. No study has evaluated the correlation of bone histomorphometry (BH) parameters with glycemic control and presence of chronic complications (CCs) in premenopausal women with T2DM. OBJECTIVES: To evaluate BH and correlate them with the degree of glycemic control and presence of CCs. DESIGN, SETTINGS, AND PATIENTS: This was a cross-sectional study conducted at a tertiary medical center. Twenty-six premenopausal women with T2DM were divided into groups with glycated hemoglobin HbA1c < 7% (good control, GC; n = 10) and HbA1c > 7% (poor control, PC; n = 16), and further subdivided into groups with (n = 9) and without (n = 17) CCs. BH parameters (bone volume [bone volume per total volume, BV/TV], trabecular thickness [Tb.Th], trabecular number [Tb.N], trabecular separation [Tb.Sp], osteoid thickness [O.Th], osteoid surface [osteoid surface per bone surface, OS/BS]), mineralizing surface [MS/BS], bone formation rate [BFR]), mineral apposition rate [MAR]) as well as serum pentosidine (PEN) and insulin-like growth factor (IGF)-1 were measured. The BH data were compared among the groups and with a BH control group (control group, CG, n = 15) matched by age, sex, and race. RESULTS: BV/TV was increased in GC (P < .001) and PC (P = .05) groups and O.th (P = .03) was smaller in the PC group than in the CG. A comparison of the groups with and without CCs with the CG showed in the group with CCs, O.Th was smaller(P = .01) and BV/TV similar to the CG (P = .11). HbA1c correlated negatively with O.Th (P = .02) and OS/BS (P = .01). There was no correlation of BH to PEN and IGF-1. CONCLUSION: BH in premenopausal patients with T2DM is affected by disease control and chronic complications.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Andrade VFC, Chula DC, Sabbag FP, et al. Bone Histomorphometry in Young Patients With Type 2 Diabetes is Affected by Disease Control and Chronic Complications. J Clin Endocrinol Metab. 2020. PMID: 31587051. doi:10.1210/clinem/dgz070

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。